- Highlights From AACR IO 2026: Breaching the Tumor Microenvironment Fortress With New CAR T and Chimeras
- Cancer Risk Estimates: What Do Those Numbers Mean?
- AACR IO 2026 Keynote Highlights: The Tale of Tregs Told by Nobel Laureate Fred Ramsdell
- Editors’ Picks, February 2026: FDA’s Accelerated Approval Pathway, Overcoming Resistance to KRAS Inhibition, and More
- AACR IO 2026 Keynote Highlights: Cancer Vaccines Are Here, and Upgrading T Cells To Thrive in the Tumor Microenvironment
- What Are the Options for Colorectal Cancer Screening?
- Experts Explore How to Treat Each Stage of Triple-negative Breast Cancer
- Empowering Young Cancer Researchers Around the World—AACR Adds New GSITA Program in Africa
- From the Bench: Innovations in Cancer Vaccines
- Cancer Immunology Research’s New Editors-in-Chief Ready to Showcase Immuno-oncology’s Next Wave
- New AACR Partnership Aims to Accelerate Research on Early Detection of High-risk Cancers
- Editors’ Picks, January 2026: Naked Mole Rat’s Cancer Resistance, the Impact of Tissue and Liquid Biopsy Concordance, and More
- Cancer Today’s Winter 2025-2026 Issue: Delaying Stem Cell Transplants in Multiple Myeloma, Emerging Treatments for Brain Metastases, and More
- What Are Fusion Proteins in Cancer?
- Combing Through Early Data to Combat the Rise in Early-onset Cancers
